All In MedTech

Device Trial Radar · NCT07784673

OsteoFlo HydroFiber Ambispective Evaluation

An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Feb 1, 2027

Study completion Feb 1, 2027

Sponsor

Lead sponsor
SurGenTec LLCNot on our public-company list
Sponsor type
Industry
First posted
Aug 25, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFiber when used to promote fusion in the lumbar spine.

Conditions

  • OsteoFlo HydroFiber

Interventions

  • OsteoFlo HydroFiberDevice

    Observational study of subjects previously implanted with OsteoFlo HydroFiber.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Qualitative FusionTime frame: 6 months post-op

3 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Duly Health and Care

    Naperville, Illinois

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.